Patient assistance program application of funds to a deductible disclosure requirement provision
Requires health insurers and patient assistance programs to disclose how pharmaceutical assistance funds apply toward insurance deductibles.
Requires health insurers and patient assistance programs to disclose how pharmaceutical assistance funds apply toward insurance deductibles.
SF 3604 requires health insurers and patient assistance programs to disclose how patient assistance funds can be applied toward insurance deductibles. The bill establishes transparency requirements around the coordination between pharmaceutical assistance programs and health insurance cost-sharing obligations, ensuring patients understand what portion of their out-of-pocket costs these programs can cover.
Patients often rely on manufacturer patient assistance programs to afford medications but may be confused about whether those funds reduce their insurance deductibles or only cover copayments and coinsurance. Without clear disclosure, patients could face unexpected out-of-pocket expenses or make uninformed decisions about treatment. This transparency requirement helps patients make better healthcare decisions and understand their actual financial obligations.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.